Table 1.
Human |
Dog |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biomarker | abbr. | LOD (μg/L) |
DF | n | GM | GM raw |
Med | 95th | 95th raw | DF | n | GM | GM raw |
Med | 95th | 95th raw |
rs |
Organophosphates | |||||||||||||||||
3,5,6-trichloro-2-pyridinol | TCPY | 0.1 | 100 | 30 | 2.25 | 1.54 | 2.29 | 5.89 | 4.68 | 100 | 30 | 1.72 | 1.61 | 1.30 | 9.92 | 11.50 | 0.22 |
para-nitrophenol | PNP | 0.1 | 100 | 30 | 1.76 | 1.21 | 1.54 | 8.63 | 7.40 | 100 | 30 | 2.91 | 2.72 | 2.86 | 6.52 | 7.59 | −0.14 |
2-isopropyl-4-methyl-6-hydroxypyrimidine | IMPY | 0.1 | 30 | 30 | N/A | N/A | 0.10 | 0.72 | 0.59 | 0 | 30 | N/A | N/A | N/A | N/A | N/A | N/A |
Phenoxy acid | |||||||||||||||||
2,4-dichorophenoxyacetic acid | 2,4-D | 0.15 | 93 | 30 | 0.54 | 0.37 | 0.55 | 1.87 | 1.65 | 97 | 30 | 0.85 | 0.8 | 0.96 | 3.94 | 5.13 | −0.23 |
Pyrethroids | |||||||||||||||||
3-ohenixybenzoic acid | 3-PBA | 0.1 | 100 | 30 | 3.39 | 2.32 | 3.47 | 21.22 | 13.49 | 20 | 30 | N/A | N/A | 0.05 | 1.53 | 0.88 | N/A |
4-fluoro-3-phenoxybenzoic acid | 4-F-3-PBA | 0.1 | 33 | 30 | N/A | N/A | 0.10 | 0.98 | 0.87 | 17 | 30 | N/A | N/A | 0.05 | 1.24 | 1.37 | N/A |
trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid | trans-DCCA | 0.6 | 60 | 30 | 2.37 | 1.62 | 3.04 | 22.16 | 13.74 | 73 | 30 | 2.82 | 2.64 | 1.47 | 368.90 | 278.85 | 0.38* |
Neonicotinoids | |||||||||||||||||
5-hydroxy imidacloprid‡ | 5-OH-IMI | 0.2 | 38 | 16‡ | 0.75 | 0.75 | 0.32 | 38.36 | 16.10 | 50 | 26‡ | 1.84 | 1.70 | 0.65 | 583.87 | 673.20 | N/A |
acetamiprid | ACET | 0.2 | 3 | 30 | N/A | N/A | N/A | N/A | N/A | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
acetamiprid-N-desmethyl‡ | ACET-Ndes | 0.4 | 48 | 29‡ | 0.83 | 0.35 | 0.76 | 5.63 | 3.49 | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
clothianidin | CLOTH | 0.4 | 0 | N/A | N/A | N/A | N/A | N/A | N/A | 3 | 30 | N/A | N/A | N/A | N/A | N/A | N/A |
imidacloprid‡ | IMI | 0.3 | 46 | 24‡ | 0.62 | 0.27 | 0.64 | 1.64 | 0.68 | 42 | 24‡ | 0.91 | 0.91 | 0.32 | 126.21 | 147.70 | N/A |
thiacloprid | THIAC | 0.2 | 0 | N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
DEET | |||||||||||||||||
3-(diethylcarbamoyl)ben zoic acid | DCBA | 0.03 | 100 | 30 | 51.06 | 21.73 | 43.16 | 21972.10 | 13874.50 | 100 | 30 | 16.82 | 15.77 | 16.21 | 255.87 | 205.00 | 0.82** |
3-(ethylcarbamoyl)benzoic acid‡ | ECBA | 0.2 | 100 | 29‡ | 20.98 | 8.96 | 20.87 | 8389.59 | 5287.80 | 83 | 30 | 4.67 | 4.38 | 5.28 | 98.33 | 71.60 | 0.87** |
p < 0.05
p < 0.0001; N/A: not applicable; LOD values are not SG-corrected. Detection frequency (DF) (%); geometric mean (GM); raw (i.e., uncorrected for specific gravity) values are also provided for comparison with NHANES data.
Some samples had mass spectrometry interferences that prevented accurate quantification of some biomarkers; these samples were excluded from statistical analyses. The “n” column indicates the number of urine samples for which data was collected and which there was no mass spectrometry interference. rs = the Spearman correlation coefficient estimated from human and dog urinary biomarkers. Analytes with a DF < 50% were not analyzed and entered as N/A.